Breast cancer genomics and immuno-oncological markers to guide immune therapies
D. Hammerl et al, 2018, Seminars in Cancer Biology CrossRef
The effect of apis Dorsata honey as a complementary therapy to interleukin-6 (IL-6) levels and T lymphocytes of post-chemotherapy breast cancer patients
Yuliana Syam et al, 2021, Breast Disease CrossRef
Cytotoxic T-lymphocyte associated-protein-4 +49A/G-allele (rs231775) single nucleotide polymorphisms are associated with acute allograft renal transplantation rejection: A multilevel modelling of meta-analysis
Besut Daryanto et al, 2022, F1000Research CrossRef
Synergistic antitumor effect of anti‐PD‐L1 combined with oxaliplatin on a mouse tumor model
Soheila Golchin et al, 2019, Journal of Cellular Physiology CrossRef
Changes in plasma EBV-DNA and immune status in patients with nasopharyngeal carcinoma after treatment with intensity-modulated radiotherapy
Qi Chen et al, 2019, Diagnostic Pathology CrossRef
Progress in research and treatment of immune checkpoints in breast cancer
Xinyi Zhang et al, 2024, Asia-Pacific Journal of Oncology CrossRef
Association of cytotoxic T‐lymphocyte antigen 4 +49A/G gene polymorphism with acute rejection risk in renal transplantation
Chun‐Hua Yang et al, 2017, Pediatric Transplantation CrossRef
Differential Response of MDA-MB-231 and MCF-7 Breast Cancer Cells to In Vitro Inhibition with CTLA-4 and PD-1 through Cancer-Immune Cells Modified Interactions
Kamil Grubczak et al, 2021, Cells CrossRef
PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer
Xiaojun Shi et al, 2017, Cancer Letters CrossRef
Combination immunotherapy with interleukin‐2 surface‐modified tumor cell vaccine and programmed death receptor‐1 blockade against renal cell carcinoma
Xinji Zhang et al, 2019, Cancer Science CrossRef
PD‐1 blockade enhances the antitumor efficacy of GM‐CSF surface‐modified bladder cancer stem cells vaccine
Xiaojun Shi et al, 2018, International Journal of Cancer CrossRef